EV/EBIT - Pharmaniaga Bhd (KLSE:PHARMA) - Alpha Spread
P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.395 MYR 1.28%
Market Cap: 569.3m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

EV/EBIT
Enterprise Value to EBIT

92.3
Current
5.3
Median
16.9
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
92.3
=
Enterprise Value
1.4B MYR
/
EBIT
15.1m MYR
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
9.8
2-Years Forward
EV/EBIT
10.1
3-Years Forward
EV/EBIT
N/A

See Also

Discover More